Lattice Semiconductor Corporation Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Lattice Semiconductor Corporation Common Stock trades at $113.11 (market cap $17.90B), while NeoGenomics Inc. Common Stock trades at $16.83 (market cap $2.14B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 8.4× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lattice Semiconductor Corporation Common Stock for 6 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| LSCC | NEO | |
|---|---|---|
Market Cap | $17.90B | $2.14B |
Volume | 1,042,232 | 2,228,400 |
Sector | Technology | Health |
52-Week High | $155.27 | $19.91 |
52-Week Low | $61.73 | $7.19 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $17.77B | $2.44B |
Signals from Pluang's Aura AI — not financial advice
Lattice Semiconductor (LSCC) trades at $121.15, down 1.38% today, with a bullish technical signal from moving averages. The company shows strong revenue growth projections from $523M in 2025 to $651M in 2026, though current valuation metrics remain elevated with a P/E of 504.2. Recent news highlights leadership in AI infrastructure security and new FPGA product launches, supported by overwhelmingly positive analyst sentiment with 88% buy ratings.
LSCC presents growth potential through AI-driven semiconductor demand and expanding product portfolio, but faces risks from high valuations and competitive pressures. The consensus price target of $162.14 suggests 34% upside, though investors should monitor execution on projected margin expansion from 0.58% to 5.57% net profit margin.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →